People who were abused and neglected during childhood have a higher risk of major depression when they become young adults, according to a report in the January issue of the Archives of General Psychiatry, one of the JAMA/Archives journals.
Undernourished women who take a vitamin and mineral supplement while pregnant may be less likely than women taking only iron and folic acid supplements to have babies weighing less than 2,500 grams, and their newborns may be less likely to have morbidity in the first seven days of life, according to a report in the January issue of Archives of Pediatrics & Adolescent Medicine, one of the JAMA/Archives journals.
In an advance in the emerging field of bacterial imaging, scientists are reporting development of a method for identifying specific sites of localized bacterial infections in living animals. Bradley D. Smith at the University of Notre Dame and colleagues describe the method in a report scheduled for the Jan. 10 edition of the Journal of the American Chemical Society, a weekly publication.
As Americans continue to live longer with chronic disease, palliative care medicine is gaining a new appreciation. While advances in modern medicine have benefited countless people and added years to peoples? lives, a new focus includes enhancing the quality of life.
In an alarming finding about alternative medical institutions, a parliamentary panel has said that 142 colleges of Ayurveda, Unani and Homoeopathy colleges in the country lack minimum infrastructure.
Adults living with children eat more saturated fat — the equivalent of nearly an entire frozen pepperoni pizza each week — than do adults who do not live with children, according to a University of Iowa and University of Michigan Health System study.
The FDA’s draft risk assessment finds that meat and milk from clones of adult cattle, pigs and goats, and their offspring, are as safe to eat as food from conventionally bred animals. The assessment was peer-reviewed by a group of independent scientific experts in cloning and animal health. They agreed with the methods FDA used to evaluate the data and the conclusions set out in the document.
GlaxoSmithKline’s new drug Tykerb dramatically slows the spread of aggressive late-stage breast cancer. Data from a Phase III study reporting that Tykerb? (lapatinib) plus Xeloda? (capecitabine) is superior to capecitabine alone in women with HER2 (ErbB2) positive advanced breast cancer who had progressed following prior therapy, including Herceptin? (trastuzumab), was published today in the New England Journal of Medicine (NEJM).
A unique Mayo Clinic collaboration has revived the healing wisdom of Pacific Island cultures by testing a therapeutic plant extract described in a 17th century Dutch herbal text for its anti-bacterial properties.
Medical teams — not individuals — are critical to the prevention of catheter-related bloodstream infections, as well as for the overall health, safety, and welfare of patients, according to an editorial by two Virginia Commonwealth University physicians published in today’s issue of the New England Journal of Medicine.